Aisle7 launches interactive solution that helps educate patients on nutrient-drug interactions
PORTLAND, Ore. — Aisle7 on Thursday announced the launch of Healthnotes Interactions Checker, a next-generation solution simplifying the task of deciding which nutrients positively or negatively interact with the medicines they take. More than half of all Americans take some form of dietary supplement, and an estimated 40% of U.S. adults take both drugs and nutrients as part of their health regimen. Of these, 60% aren’t discussing possible interactions with their physician or pharmacist, Aisle7 noted.
“Over the last several months, we’ve spoken with pharmacists, doctors and our retail partners who tell us they see both a customer service and an information gap in the current prescription information delivery systems,” stated Skye Lininger, CEO of Aisle7. “The Healthnotes Interactions Checker solves this problem by seamlessly integrating with our clients’ environments—whether pharmacy-management systems, e-commerce sites, mobile platforms or health professional tools.”
“Today’s healthcare professionals are looking for the tools and resources they need to spend less time managing their business and more time caring for patients,” added Mandy Kraynik, VP Integrative Therapeutics. “Partnering with Aisle7 to introduce an interactive drug-nutrient interaction checker allows us to provide value to our customers in meaningful ways outside of nutritional supplements. Making new, dynamic tools like this available to healthcare professionals exemplifies our commitment to the integrative medicine community.”
The Healthnotes Interactions Checker has a simple interface: a person enters their current drugs and supplements into the list and the resulting report is easy-to-read and color-coded to clearly identify nutrients that have adverse or beneficial interactions with their medications. Reports can be printed or emailed to read later and share with a health professional.
Reports can also be automatically triggered as part of a prescription refill. The Healthnotes Interactions Checker accepts National Drug Codes from external pharmacy systems to create customized reports. When a refill is requested, a report can be auto-generated and delivered directly to the patient’s mobile phone. Or it can be made available at prescription pickup to discuss with their pharmacist, who can then highlight the nutrients to avoid due to safety concerns and which to add to support a medicine’s effectiveness or reduce side effects.
Alleradd launches supplement to support mental function as alternative to energy products
HOUSTON — Alleradd on Wednesday launched its namesake product — a dietary supplement product to help students focus as a healthy, quick-acting alternative to energy products with no harmful side effects.
Alleradd was developed by two college graduates and former financial engineers, Lucas Siegel and Matthew Piskorz. "Sophomore year, I realized there is something deeper and darker about [prescription-only alertness alternatives]," stated Siegel. "These miracle drugs people are using to study are much more than just performance-enhancing study drugs, they are amphetamines. I was literally sitting there watching some of my friends spiral out of control."
So Siegel and Piskorz worked with a nutraceutical manufacturer and formulated a unique combination of 18 ingredients including GABA, vitamin D-3, alpha-lipoic acid and DMAE that is scientifically formulated to promote a balance of elevated focus, mood and mental drive.
"Our product isn’t as strong as prescription ADHD medication and is not intended to cure any disease," Siegel said. "We have found that it’s possible to amplify mental performance and energy without straining the body with harmful and powerful prescription drugs. Alleradd is designed for people who need energy, attention, and the power to accelerate their lives."
The brand is presently available for a suggested $34.95 at www.alleradd.com.
NACDS, NCPA endorse legislation to restore OTC purchase eligibility under FSAs, HSAs
ALEXANDRIA, Va. — New Senate legislation introduced Tuesday that would restore consumers’ ability to use pre-tax dollars from flexible spending accounts and health savings accounts to purchase over-the-counter medicines without first seeing a doctor has been jointly endorsed by the National Association of Chain Drug Stores and the National Community Pharmacists Association.
NACDS and NCPA are part of the Health Choices Coalition, which sent a letter of endorsement to the bill’s leading sponsors. “Consumers depend on OTC medicines as a first line of defense for their families’ health care needs,” the coalition wrote. “OTC medicines provide Americans with effective, affordable, convenient and accessible means to address their health care needs. These medicines save consumers billions of dollars annually through reducing unnecessary doctors’ visits, less time lost from work, and the cost advantage of OTC medicines.”
The legislation, S. 1647, repeals section 9003 of the Patient Protection and Affordable Care Act, restoring the ability of those participating in a medical savings account to use the funds to purchase OTC medications. Nearly 50 million Americans participate in FSAs and other health savings accounts, Roberts noted.
Companion legislation was introduced in the U.S. House of Representatives by Reps. Lynn Jenkins, R-Kan., and John Barrow, D-Ga. Similar legislation passed the House last year.
The bill was cosponsored by Sens. Jim Inhofe, R-Okla., Orrin Hatch, R-Utah, Mike Enzi, R-Wyo., Johnny Isakson, R-Ga., Mike Johanns, R-Neb., and Dean Heller, R-Nev.